Home » Ozempic-maker Novo open to upgrading US listing

Ozempic-maker Novo open to upgrading US listing

Ozempic-maker Novo open to upgrading US listing

This post was originally published on this site.

Boss Mike Doustdar says he sees ‘advantages’ in giving US investors direct access to Danish group’s stock